切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Smoothened - TAM kinase - Insulin and Insulin-like Receptors - D1 and D5 Receptors

16件产品中的 1-10

页面
每页
清除全部
  1. LDC1267
    B4893 LDC1267
    Target: TAM kinase
    Summary: TAM激酶抑制剂
      ≥20.75 mg/mL
      insoluble in H2O
  2. Fenoldopam
    B1483 Fenoldopam
    中文名: 非诺多泮
    Target: D1 and D5 Receptors
    Summary: D1样多巴胺受体部分激动剂
      ≥15.29 mg/mL
      ≥12.55 mg/mL
  3. Pergolide mesylate
    B1485 Pergolide mesylate
    中文名: 甲磺酸培高利特
    Target: D1 and D5 Receptors|D2 Receptors
    Summary: 多巴胺能激动剂
      ≥6.84 mg/mL
      insoluble in H2O
  4. Quetiapine Fumarate
    B1490 Quetiapine Fumarate
     1 Citation
    中文名: 富马酸奎硫平
    Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|5-HT7 Receptors
    Summary: 多巴胺受体拮抗剂
      ≥11.03 mg/mL
      insoluble in H2O
  5. LDE225 (NVP-LDE225,Erismodegib)
    B2266 LDE225 (NVP-LDE225,Erismodegib)
     1 Citation
    中文名: 索尼德吉
    Target: Smoothened
    Summary: Smoothened抑制剂
      ≥24.3 mg/mL
      insoluble in H2O
  6. Clozapine
    B2235 Clozapine
    中文名: 氯氮平
    Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|D4 Receptors
    Summary: 5-HT受体拮抗剂
      ≥14.95 mg/mL
      insoluble in H2O
  7. PF-04449913
    B3283 PF-04449913
    中文名: 格拉吉布
    Target: Smoothened
    Summary: Smoothened拮抗剂
      ≥20.15 mg/mL
      insoluble in H2O
  8. Thioridazine HCl
    A8537 Thioridazine HCl
    中文名: 盐酸硫利达嗪,盐酸硫代利哒,甲硫达嗪盐酸盐,甲硫哒嗪盐酸盐
    Target: Cytochrome P450 (CYP450)|D1 and D5 Receptors|D2 Receptors|D3 Receptors|D4 Receptors
    Summary: 钙通道蛋白抑制剂
      ≥20.35 mg/mL
      ≥6.78 mg/mL
  9. GSK1838705A
    A8440 GSK1838705A
    Target: Insulin and Insulin-like Receptors|ALK
    Summary: ATP竞争性IGF-IR/IR/ALK抑制剂
      ≥26.65 mg/mL
      insoluble in H2O
  10. Cyclopamine
    A8340 Cyclopamine
     1 Citation
    中文名: 环巴胺
    Target: Smoothened
    Summary: Hedgehog (Hh)信号抑制剂
      ≥6.86 mg/mL
      insoluble in H2O

16件产品中的 1-10

页面
每页